DrugPatentWatch Database Preview
FLUORODOPA F-18 - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for fluorodopa f-18 and what is the scope of patent protection?
Fluorodopa f-18
is the generic ingredient in one branded drug marketed by Feinstein and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for FLUORODOPA F-18
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 6 |
| Clinical Trials: | 10 |
| Patent Applications: | 120 |
| DailyMed Link: | FLUORODOPA F-18 at DailyMed |
Recent Clinical Trials for FLUORODOPA F-18
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Thomas Jefferson University | Phase 2 |
| Washington University School of Medicine | Phase 1 |
| Erik Mittra | N/A |
US Patents and Regulatory Information for FLUORODOPA F-18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feinstein | FLUORODOPA F18 | fluorodopa f-18 | SOLUTION;INTRAVENOUS | 200655-001 | Oct 10, 2019 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
